JPRN-C000000092已完成2 期
Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14) - Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 108 人开始时间: 2005年8月30日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.severe comorbidity (e.g. severe infectious disease, heart failure, respiratory dysfunction, hepatic failure, liver cirrhosis, renal failure, active peptic ulcer, insulin dependent diabetes mellitus 2. other active neoplasms 3. psychological disease 4. expected survival ; less than 3 months 5. Pregnant women 6. Past history of myocardial infarction 7. Positive for HTLV-1
研究者
相似试验
已完成
2 期
Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)JPRN-C000000068Japan Clinical Oncology Group(JCOG)108
已完成
2 期
A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: initial report of Japan Clinical Oncology Group trial (JCOG 9806)JPRN-C000000031Japan Clinical Oncology Group(JCOG)75
已完成
2 期
Randomized phase II study of two induction treatments of melphalan, prednisolone, plus bortezomib, JCOG-MPB versus modified PETHEMA-MPB, in elderly patients or non-elderly patients refusing transplant with untreated symptomatic myeloma(JCOG1105, IMPROVE-MPB study)Elderly patients or non-elderly patients refusing transplant with untreated symptomatic myelomaJPRN-UMIN000011180Japan Clinical Oncology Group (JCOG)91
已完成
2 期
Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)JPRN-UMIN000001272Japan Clinical Oncology Group (JCOG)45
已完成
2 期
Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)JPRN-C000000032Japan Clinical Oncology Group(JCOG)80